Aquestive Therapeutics Current Ratio 2018-2019 | AQST

Aquestive Therapeutics current ratio from 2018 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Aquestive Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.04B $0.03B 1.59
2019-03-31 $0.06B $0.03B 1.89
2018-12-31 $0.07B $0.03B 2.25
2018-09-30 $0.08B $0.02B 3.63
2018-06-30 $0.03B $0.02B 1.14
2018-03-31 $0.00B 0.00
2017-12-31 $0.00B 0.00
2017-09-30 $0.00B 0.00
2017-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.084B $0.067B
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based in NJ, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $61.466B 37.86
Takeda Pharmaceutical (TAK) Japan $54.955B 8.60
Astellas Pharma (ALPMY) Japan $30.027B 14.31
Merck (MKGAF) Germany $14.908B 20.34
Eisai (ESALY) Japan $14.633B 22.40
UCB SA (UCBJF) Belgium $14.373B 0.00
Grifols, S.A (GRFS) Spain $14.157B 18.06
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Ionis Pharmaceuticals (IONS) United States $8.635B 18.62
Neurocrine Biosciences (NBIX) United States $8.562B 0.00
IPSEN SA ADR (IPSEY) France $8.332B 0.00
Sage Therapeutics (SAGE) United States $7.452B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Catalent (CTLT) United States $7.196B 28.44
Jazz Pharmaceuticals (JAZZ) Ireland $6.684B 8.80
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.118B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.194B 18.67
United Therapeutics (UTHR) United States $3.594B 0.00
FibroGen (FGEN) United States $3.378B 84.48
Evotec AG (EVTCY) Germany $3.277B 44.87
Arrowhead Pharmaceuticals (ARWR) United States $3.256B 74.66
Nektar Therapeutics (NKTR) United States $3.031B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.912B 10.44
PTC Therapeutics (PTCT) United States $2.228B 0.00
Tilray (TLRY) Canada $2.160B 0.00
Xencor (XNCR) United States $1.988B 43.35
Zogenix (ZGNX) United States $1.879B 0.00
Portola Pharmaceuticals (PTLA) United States $1.874B 0.00
Corcept Therapeutics (CORT) United States $1.633B 22.44
Pacira Pharmaceuticals (PCRX) United States $1.586B 57.73
USANA Health Sciences (USNA) United States $1.535B 15.39
Heron Therapeutics (HRTX) United States $1.424B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.413B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.203B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.171B 19.31
ArQule (ARQL) United States $1.038B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.956B 0.00
TherapeuticsMD (TXMD) United States $0.944B 0.00
Aerie Pharmaceuticals (AERI) United States $0.932B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.873B 3.89
Spectrum Pharmaceuticals (SPPI) United States $0.870B 0.00
Dova Pharmaceuticals (DOVA) United States $0.809B 0.00
Endo (ENDP) Ireland $0.790B 1.39
Organogenesis Holdings (ORGO) United States $0.719B 0.00
Karyopharm Therapeutics (KPTI) United States $0.647B 0.00
Concordia (CXRXF) Canada $0.588B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.542B 0.00
Flexion Therapeutics (FLXN) United States $0.539B 0.00
Akebia Therapeutics (AKBA) United States $0.513B 0.00
Indivior (INVVY) United States $0.473B 1.71
Aptorum Group (APM) Hong Kong, SAR China $0.466B 0.00
Lannett Co Inc (LCI) United States $0.453B 4.77
ChemoCentryx (CCXI) United States $0.450B 0.00
Siga Technologies (SIGA) United States $0.446B 1.04
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.440B 0.00
Translate Bio (TBIO) United States $0.426B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.406B 0.00
Collegium Pharmaceutical (COLL) United States $0.403B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.366B 16.64
ImmunoGen (IMGN) United States $0.366B 0.00
Innate Pharma SA (IPHYF) France $0.363B 0.00
DURECT (DRRX) United States $0.355B 0.00
Rafael Holdings (RFL) United States $0.334B 0.00
Harpoon Therapeutics (HARP) United States $0.324B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.313B 0.00
OptiNose (OPTN) United States $0.293B 0.00
Dermira (DERM) United States $0.289B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.283B 0.00
Ardelyx (ARDX) United States $0.277B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.276B 0.00
Molecular Templates (MTEM) United States $0.260B 0.00
Recro Pharma (REPH) United States $0.258B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.227B 0.00
Xeris Pharmaceuticals (XERS) United States $0.217B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.206B 0.00
GlycoMimetics (GLYC) United States $0.199B 0.00
CannTrust Holdings (CTST) Canada $0.195B 0.00
CV Sciences (CVSI) United States $0.193B 0.00
KalVista Pharmaceuticals (KALV) United States $0.191B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 30.45
AcelRx Pharmaceuticals (ACRX) United States $0.175B 0.00
Taiwan Liposome (TLC) Taiwan $0.168B 0.00
Ocular Therapeutix (OCUL) United States $0.156B 0.00
Concert Pharmaceuticals (CNCE) United States $0.148B 0.00
Calithera Biosciences (CALA) United States $0.140B 0.00
Redhill Biopharma (RDHL) Israel $0.136B 0.00
IMV INC (IMV) Canada $0.129B 0.00
Generex Biotechnology (GNBT) United States $0.129B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.128B 0.00
MEI Pharma (MEIP) United States $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.117B 0.00
Jounce Therapeutics (JNCE) United States $0.110B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 32.53
Majesco Entertainment (PTE) United States $0.081B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.081B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Lipocine (LPCN) United States $0.072B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
Genocea Biosciences (GNCA) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.070B 0.00
Otonomy (OTIC) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
AgeX Therapeutics (AGE) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.065B 9.73
Novan (NOVN) United States $0.062B 0.00
IntelGenx Technologies (IGXT) Canada $0.062B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
Aclaris Therapeutics (ACRS) United States $0.061B 0.00
Melinta Therapeutics (MLNT) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
Capnia (SLNO) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Mast Therapeutics (SVRA) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
India Globalization Capital (IGC) United States $0.036B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
Bio-Path Holdings (BPTH) United States $0.032B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.031B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Opexa Therapeutics (ACER) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Vical (BBI) United States $0.014B 0.00
Heat Biologics (HTBX) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 17.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00